Original paper
Bevacizumab zur Therapie des sekundären Makulaödems nach venösen Gefäßverschlüssen
Abstract
Application of VEGF inhibitors represents a treatment option for macular edema secondary to retinal vein occlusion that targets the disease at the causal molecular level. First reports on intravitreal injections of bevacizumab show promising morphological and functional effects and demonstrate that bevacizumab is a potent antiedematous agent in this context. A significant reduction of the central retinal thickness followed by a rapid improvement...
Paper Details
Title
Bevacizumab zur Therapie des sekundären Makulaödems nach venösen Gefäßverschlüssen
Published Date
Jun 1, 2006
Journal
Volume
103
Issue
6
Pages
471 - 475
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History